Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $99.7B |
| FY2017, ended Dec 31, 2017 | $137B |
| FY2018, ended Dec 31, 2018 | $136B |
| FY2019, ended Dec 31, 2019 | $147B |
| FY2020, ended Dec 31, 2020 | $160B |
| FY2021, ended Dec 31, 2021 | $199B |
| FY2022, ended Dec 31, 2022 | $193B |
| FY2023, ended Dec 31, 2023 | $214B |
| FY2024, ended Dec 31, 2024 | $207B |
| FY2025, ended Dec 31, 2025 | $217B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $191B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $24.6B |
| FY2017, ended Dec 31, 2017 | $22.8B |
| FY2018, ended Dec 31, 2018 | $21.3B |
| FY2019, ended Dec 31, 2019 | $21.4B |
| FY2020, ended Dec 31, 2020 | $19.2B |
| FY2021, ended Dec 31, 2021 | $23.2B |
| FY2022, ended Dec 31, 2022 | $23.2B |
| FY2023, ended Dec 31, 2023 | $25.5B |
| FY2024, ended Dec 31, 2024 | $25.9B |
| FY2025, ended Dec 31, 2025 | $26.9B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $27.7B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $4.69B | $4.24B |
| FY2017, ended Dec 31, 2017 | $5.19B | $3.70B |
| FY2018, ended Dec 31, 2018 | $5.92B | $4.22B |
| FY2019, ended Dec 31, 2019 | $6.03B | $5.73B |
| FY2020, ended Dec 31, 2020 | $4.73B | $4.62B |
| FY2021, ended Dec 31, 2021 | $7.55B | $7.10B |
| FY2022, ended Dec 31, 2022 | $6.18B | $5.49B |
| FY2023, ended Dec 31, 2023 | $8.47B | $7.25B |
| FY2024, ended Dec 31, 2024 | $8.22B | $6.67B |
| FY2025, ended Dec 31, 2025 | $8.56B | $7.19B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $8.79B | $7.76B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $1.22B |
| FY2017, ended Dec 31, 2017 | $2.46B |
| FY2018, ended Dec 31, 2018 | $866M |
| FY2019, ended Dec 31, 2019 | $899M |
| FY2020, ended Dec 31, 2020 | $3.45B |
| FY2021, ended Dec 31, 2021 | $4.71B |
| FY2022, ended Dec 31, 2022 | $2.58B |
| FY2023, ended Dec 31, 2023 | $4.58B |
| FY2024, ended Dec 31, 2024 | $1.08B |
| FY2025, ended Dec 31, 2025 | $774M |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $822M |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | $26.0B |
| FY2017, ended Dec 31, 2017 | $29.5B |
| FY2018, ended Dec 31, 2018 | $31.1B |
| FY2019, ended Dec 31, 2019 | $34.2B |
| FY2020, ended Dec 31, 2020 | $37.4B |
| FY2021, ended Dec 31, 2021 | $35.6B |
| FY2022, ended Dec 31, 2022 | $35.9B |
| FY2023, ended Dec 31, 2023 | $41.5B |
| FY2024, ended Dec 31, 2024 | $38.4B |
| FY2025, ended Dec 31, 2025 | $40.8B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $39.9B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Down 13.6% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 819M |
| FY2017, ended Dec 31, 2017 | 794M |
| FY2018, ended Dec 31, 2018 | 765M |
| FY2019, ended Dec 31, 2019 | 745M |
| FY2020, ended Dec 31, 2020 | 746M |
| FY2021, ended Dec 31, 2021 | 744M |
| FY2022, ended Dec 31, 2022 | 731M |
| FY2023, ended Dec 31, 2023 | 722M |
| FY2024, ended Dec 31, 2024 | 714M |
| FY2025, ended Dec 31, 2025 | 710M |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | 708M |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $11.2B | $131M |
| FY2017, ended Dec 31, 2017 | $4.69B | $118M |
| FY2018, ended Dec 31, 2018 | $5.21B | $125M |
| FY2019, ended Dec 31, 2019 | $4.98B | $110M |
| FY2020, ended Dec 31, 2020 | $908M | $92.4M |
| FY2021, ended Dec 31, 2021 | $846M | $139M |
| FY2022, ended Dec 31, 2022 | $3.90B | $167M |
| FY2023, ended Dec 31, 2023 | $3.05B | $175M |
| FY2024, ended Dec 31, 2024 | $2.82B | $172M |
| FY2025, ended Dec 31, 2025 | $2.06B | $165M |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $2.33B | $175M |
Valuation
At current price- Market Cap
- $177B
- P/E
- 20.1×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 6.4×
- Price / Book
- n/m. Market cap / shareholders' equity
- EV / EBITDA
- 16.2×
Growth
Trailing 12 months- Revenue (TTM)
- $27.7B
- Revenue Growth YoY
- 6.3%
- Revenue CAGR 3Y
- 5.1%
- Revenue CAGR 5Y
- 7.0%
- EPS Growth YoY
- 5.5%
- Net Income Growth YoY
- 4.7%
Profitability
Trailing 12 months- Gross Margin
- —
- Operating Margin
- 46.2%
- Net Margin
- 31.7%
- FCF Margin
- 28.0%
- Return on Equity
- n/m. Net income (TTM) / average equity
Earnings
Trailing 12 months- Net Income
- $8.79B
- EPS (diluted)
- $12.31
- EBITDA
- $13.3B
- Operating Income
- $12.8B
Balance Sheet
As of Jun 30, 2026- Cash and cash equivalents
- $822M
- Total Debt
- $39.9B
- Net Debt
- $39.0B
- Total Assets
- $59.9B
- Total Liabilities
- $60.9B
- Shareholders' Equity
- −$1.02B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $11.3B
- Capital Expenditure
- $3.59B
- Free Cash Flow
- $7.76B
Dividends and risk
Last 12 months- Dividend Yield
- 3.0%
- Dividend / Share
- $7.44
- Beta (5Y)
- 0.44
Every ratio is calculated from the company’s reported figures.